Skip to main content

Highlights

  1. 1
    Communications biology · 2023
    PMID: 36599970PMCID: PMC9812973DOISenior author29 citations
  2. 2
    Cell reports · 2020
    PMID: 32783948DOISenior author31 citations
  3. 3
    Science advances · 2022
    PMID: 35263130PMCID: PMC8906729DOISenior author13 citations

Publications

46 publications

Active

1 grant
  • PI
    Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028
    R01HD112441-04
Completed grants (1)
  • PI
    Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2024
    R21HD103956-02

Clinical research

3 studies

Active

3 studies
  • PI
    Nanosensor Observations for Timely Identification of Complications after Embryo Transfer
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    QUANTUM DEFECT-MODIFIED CARBON NANOTUBE ARRAYS in IVF
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Differences in RNA profiles in Granulosa cells from mature versus immature oocytes
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)

News mentions

  • Anti-Müllerian Hormone May Contribute to Infertility in Polycystic Ovary Syndrome
    March 9, 2022

    High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by Weill Cornell Medicine researchers suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility.

Mentoring

1 mentee